Verified earnings results
Inhibrx Biosciences Q3 2026 Earnings Results
Direct answer
Inhibrx Biosciences reported Q3 2026 results on November 13, 2026.
Revenue was 2,000,000. EPS beat the estimate by 4.41%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Inhibrx Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 13, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -2.5735
- Reported EPS
- -2.46
- Revenue
- 2,000,000
- EPS surprise
- EPS beat the estimate by 4.41%.
Explore related company data
Read the frequently asked questions.
When did Inhibrx Biosciences report Q3 2026 earnings?
Inhibrx Biosciences reported on November 13, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Inhibrx Biosciences?
The verified record provides an EPS estimate of -2.5735.
Has Inhibrx Biosciences reported the Q3 2026 result?
Revenue was 2,000,000. EPS beat the estimate by 4.41%.
Which source supports this Inhibrx Biosciences earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.